1. Thalidomide metabolism by the CYP2C subfamily;Clin. Cancer Res.,2002
2. Inhibition of thalidomide teratogenicity by acetylsalicylic acid: evidence for prostaglandin H synthase-catalyzed bioactivation of thalidomide to a teratogenic reactive intermediate;J. Pharmacol. Exp. Ther.,1996
3. A study of vehicles for dosing rodent whole embryo culture with non-aqueous soluble compounds;Reprod. Toxicol.,2004
4. Variable in vivo embryoprotective role for ataxia telangiectasia-mutated (Atm) against endogenous and phenytoin-enhanced oxidative stress in Atm knockout mice;Toxicol. Sci.,2006
5. A developmental role for antaxia-telangiectasia mutated (ATM) in protecting the embryo from spontaneous and phenytoin-enhanced embryopathies in culture;Toxicol. Sci.,2006